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Abstract. Aim: Phyllodes tumor are rare fi broepithelial neoplasms that account for less than 1% 
of all breast neoplasms. They usually present as fast growing, clinically benign lesion. They 
usually occur in middle-age women (40-50 years). At mammography or ultrasound, phyllodes 
tumors mostly present as well-circumscribed oval or lobulated lesion similar to fi broadenoma. 
A diagnosis is made by histopathologic tumor analysis which shows biphasic characteristi cs: 
epithelial and stomal component. The analysis of the stromal component is crucial as the 
stromal component determines its malignant potenti al. A phyllodes tumor can be diffi  cult to 
disti nguish from a proliferati ve fibroadenoma at core needle biopsy so fi nal histopathologic 
classifi cati on requires surgical excision. Malignant phyllodes tumors with heterologous 
components are extremely rare. Case report: We present a case of 35-year-old woman who 
had excisional biopsy of both breasts due to fi broadenomas 5 years ago. On the last ultrasound 
exam, a newly developed lesion of the right breast was detected with benign morphologic 
characteristi c so a fi ne needle aspirati on was performed. At breast examinati on, a fi rm, mobile 
mass was palpated, without signs of local ti ssue infi ltrati on. Based on the obtained fi ndings, a 
benign lesion was considered so excisional biopsy of the enti re lesion was performed. 
Conclusion: The authors present a rare case of a young pati ent with previous excision biopsies 
due to multi ple fi broadenomas who developed a recurrent tumor with benign clinical 
characteristi cs. The patohistological analysis showed that it was a case of malignant phyllodes 
tumor with heterologous liposarcomatous diff erenti ati on manifesti ng as a collision tumor 
adjacent to a complex fi broadenoma.
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Sažetak. Cilj: Filodes tumori su rijetke fi broepitelne neoplazme koje obuhvaćaju < 1 % svih 
novo tvorina dojke. Uglavnom se prezenti raju kao brzorastući, klinički benigni čvorovi pretežno 
u četvrtom i petom desetljeću života. Mamografske i ultrazvučne karakteristi ke fi lodes tumora 
su poput dobroćudnih lezija dojki s obzirom na to da se prezenti raju kao oštro ograničene, 
ovalne ili okrugle lezije nalik fi broadenomu. Dijagnoza se postavlja patohistološkom analizom 
tumora koji ima bifazične karakteristi ke: epitelnu i stromalnu komponentu. Pažljiva 
karakterizacija stromalne komponente je kriti čna, budući da su upravo karakteristi ke stromalnih 
stanica one koje određuju njegov maligni potencijal. Temeljem širokoiglene biopsije ne može se 
sa sigur nošću razlikovati  fi lodes tumor od proliferati vnog fi broadenoma, stoga konačna 
patohistološka dijagnoza zahti jeva eksciziju lezije. Maligni fi lodes tumori heterologne diferen-
cija cije vrlo su rijetki. Prikaz slučaja: Prikazujemo slučaj 35-godišnje žene kojoj su prije 5 godina 
eksti rpirani fi broadenomi obiju dojki. Na posljednjem ultrazvučnom pregledu nađena je 
novonastala lezija desne dojke morfološki dobroćudnih karakteristi ka te je učinjena aspiracijska 
punkcija. Klinički se palpirao bezbolni pomični tvrđi čvor. Klinička dijagnoza upućivala je na 
tumor benignih karakteristi ka te je pacijenti ci učinjena tumorektomija u lokalnoj anesteziji. 
Zaključak: Radi se o slučaju pacijenti ce kod koje se nakon multi plih fi broadenoma razvio 
recidivni tumor klinički benignih karakteristi ka, ali je patohistološka analiza pokazala da se radi 
o malignom fi lodes tumoru u blizini kojeg se nalazio kompleksni fi broadenom, što bi moglo 
upućivati  na malignu transformaciju fi broadenoma u maligni fi lodes tumor. 
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INTRODUCTION
Phyllodes tumors (PT) are rare fi broepithelial tu-
mors of the breast. They represent approximate-
ly 2-3% of breast fi broepithelial neoplasms, and 
less than 1% of breast tumors1. Fibroepithelial le-
sions may be benign (fi broadenoma, tubular ad-
enoma) or potenti ally malignant (phyllodes 
tumor). The diagnosis consists of pathohistologi-
cal evaluati on of the tumor, which has biphasic 
characteristi cs: epithelial and stromal elements. 
nomas (FA). In 2014, her annual ultrasound 
examinati on revealed a newly formed solid lesion 
of the right breast measuring 2.4 cm. The detect-
ed mass was oval, hyperechoic with lobulated 
margins and hypoechoic rim, parallel oriented to 
the skin (fi gure 1). At the site, fi ne needle aspira-
ti on (FNA) was performed and cytological fi nd-
ings showed sporadic vacuolizati on of the 
cytoplasm in the stromal cells with rare larger 
and bare nuclei was observed with increased cel-
lularity of the stroma. These fi ndings were sug-
gesti ve of phyllodes tumor with heterologous 
adipocyte diff erenti ati on. At breast examinati on, 
a fi rm, mobile and painless 2.5 cm mass was pal-
pated at the 9 o’clock positi on of the right breast, 
without signs of local ti ssue infi ltrati on. Based on 
the obtained clinical and cytological fi ndings con-
sistent with PT, excisional biopsy of the enti re le-
sion was performed. 
The macroscopic clip of the breast ti ssue meas-
ured 5 × 3.5 × 2.5 cm. On transverse secti on it 
was white colored, of rubber consistency, with a 
central yellow soft  leaf-like node. The margins 
were partly round and well limited with regions 
of yellowish nodules infi ltrati ng the surrounding 
ti ssue. Microscopically, the node was composed 
of thin leaf-like spaces, lined with epithelium. 
The stroma was hypercellular, with signifi cant cell 
atypia, numerous mitoses, infi ltrati ng margins, 
stromal outgrowing, and with a malignant heter-
ologous component – myxoid liposarcoma. Un-
der the same surgical procedure, another solid, 
lobular lesion was removed from the right breast, 
patohistologically described as complex FA with 
myxoid stroma, measuring 3 × 2 × 1.5 cm. 
Notwithstanding the suggesti ons in the current 
literature that wide excision with adequate nega-
ti ve surgical margins could be adequate treat-
ment even for the malignant form of PT, because 
of the risk of local recurrence (reported as 20% – 
30%), and the pati ent’s preference, mastectomy 
of the right breast with immediate reconstruc-
ti on with silicone breast implant was 
performed3-4. Prior to mastectomy, magneti c res-
onance imaging of the breast demonstrated ex-
tremely dense breast parenchyma with marked 
background contrast enhancement with no signs 
of malignant lesions. Mammography was not 
performed due to the pati ent’s age. 
Figure 1. Ultrasound image of an oval, hyperechoic lobulated mass, 
parallel to the skin surface
Adequate preoperati ve diagnosis of the phyllodes 
tumor is important because of its malignant potenti al 
and its tendency to recur and so that proper manage-
ment of the tumor, which oft en does include surgery, 
can be pursued as early as possible.
Precise characterizati on of the connecti ve ti ssue 
is required in view of the fact that stromal com-
ponents are crucial for the assessment of the ma-
lignant potenti al of the tumor2. Complete surgical 
removal of the tumor is mandatory due to the 
high risk of local recurrence3-4. 
CASE REPORT
Our pati ent was a 35-year-old woman who pre-
sented with newly developed lesions of the right 
breast. She had no personal or family history of 
breast cancer. In 2009, the pati ent underwent ex-
cisional biopsy of both breasts due to fi broade-
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Pathohistological examinati on of the remaining 
breast ti ssue aft er mastectomy demonstrated 
three additi onal lesions of the right breast, all of 
them proven to be FA, and numerous foci of fi -
broti c changes and adenomatous hyperplasia of 
the breast.
Oncological treatment in the form of radiothera-
py or chemotherapy was not conducted.
DISCUSSION
Phyllodes tumor typically manifests as a rapidly 
growing, large palpable mass and may be charac-
terized according to pathologic findings as a be-
nign lesion or as low-grade (borderline) or 
high-grade malignancy5. Sonographic appearance 
of smaller phyllodes tumor (< 5 cm) may grossly 
resemble FA6. In our case, a PT was suspected on 
ultrasound due to complex appearance of lobu-
lated lesions and known history of multi ple FAs. 
Fibroadenomas have long been considered 
benign hyperplasti c lesions rather than true 
neoplasti c processes. However, malignant trans-
formati on of breast FA to malignant PT has been 
reported in the literature7.
Although core needle biopsy (CNB) is a method 
of choice for making preoperati ve diagnosis of 
breast lesions, in a setti  ng of fi broepithelial le-
sions with FA at one end of the spectrum and a 
malignant PT at the other, accuracy in diff erenti -
ati ng these two enti ti es is not so straightf orward. 
Because of the heterogeneity and overlap in the 
histology of both benign and malignant fi broepi-
thelial tumors the disti ncti on between them may 
be diffi  cult and depending on several factors, in-
cluding cellular atypism, mitoti c acti vity, stromal 
cellularity and overgrowth, and borderline char-
acteristi cs8. Typical features that indicate malig-
nant PT are tumor invasion into surrounding 
ti ssue, stromal overgrowth, increased cellular 
pleomorphism, and mitoti cally acti ve stroma 
with > 5 mitoses/10 high-power fi elds. Diagnosis 
of PT prior to excisional biopsy or lumpectomy is 
uncommon9. Therefore, unless the core biopsy 
shows only the classic features of a FA, PT should 
be considered. 
Variati ons of the stromal cellularity, which is a 
crucial pathohistological element, can be found 
in FA, as well in PT11. Treatment of both histologi-
cal subtypes, benign and malignant PT, requires 
complete surgical excision with clear margins of 1 
cm or greater due to the high risk of local recur-
rence3. If not removed completely, tumors recur 
in up to 20% of cases4. Positi ve margins, fi bropro-
liferati on in the surrounding breast ti ssue, and 
necrosis are associated with a marked increase in 
local recurrence rates4. Malignant PT demon-
strates a wide spectrum of biologic behavior, and 
some have the potenti al for invasive growth, re-
currence, or metastasis in rare cases11. There are 
no imaging characteristi cs that could disti nguish 
benign from malignant PT and only limited infor-
mati on can be assessed by magneti c resonance 
imaging12. In a study by Yabuuchi et al, 30 benign, 
intermediate, and malignant PTs were compared. 
Tumors that were hypo- to -iso intense relati ve to 
normal breast parenchyma on T2-weighted im-
ages or that had a low apparent diff usion coeffi  -
cient signal on diff usion-weighted images were 
more likely to demonstrate the unfavorable his-
tological feature of stromal hypercellularity13. 
The complex FA near to the newly developed tu-
mor could indicate a transformati on of fi broade-
noma into malignant phyllodes tumor with 
heterologous liposarcomatous diff erenti ati on. 
CONCLUSION
In conclusion, this was a rare case of a young pa-
ti ent with previous excision biopsies due to mul-
ti ple FA who developed a recurrent tumor with 
benign clinical characteristi cs. The pathological 
report aft er lumpectomy and revised cytological 
fi ndings were consistent with malignant PT with 
sarcomatous elements, which resulted in right 
breast mastectomy.
Adequate preoperati ve diagnosis of the phyl-
lodes tumor is important because of its malig-
nant potenti al and its tendency to recur and so 
that proper management of the tumor, which of-
ten does include surgery, can be pursued as early 
as possible. There is no reliable way to disti n-
guish between phyllodes tumors and other be-
nign appearing tumors on ultrasound or 
mammography. Diagnosti cally, lumpectomy rep-
resents a consistent means for pre-operati ve di-
agnosis. Treatment can be either wide local 
excision or mastectomy to achieve histologically 
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clear margins. In our case, mastectomy with im-
mediate reconstructi on was considered to be the 
appropriate surgical procedure.
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